Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist used in pharmaceutical manufacturing. It is a chemical compound supplied as an active pharmaceutical ingredient for research and development applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Linzagolix?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ganirelix
pharmaceutical raw material
Ganirelix acetate
pharmaceutical raw material
Cetrotide
pharmaceutical raw material
Abarelix
pharmaceutical raw material
Ceftolozane sulfate
pharmaceutical raw material
PCI-32765 (Racemate)
pharmaceutical raw material
Ibrutinib
pharmaceutical raw material
Ibrutinib, (S)-
pharmaceutical raw material
The international HS code for Linzagolix (CAS 935283-04-8) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
3-[5-[(2,3-difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxyphenyl]-2,4-dioxo-1H-thieno[3,4-d]pyrimidine-5-carboxylic acid
BMAAMIIYNNPHAB-UHFFFAOYSA-N
COC1=C(C(=C(C=C1)F)F)COC2=C(C=C(C(=C2)N3C(=O)C4=C(SC=C4NC3=O)C(=O)O)F)OC
Sourcing Linzagolix?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.